Q Li1, S Lu2, X Li3, G Hou4, L Yan2, W Zhang2, B Qiao2. 1. Department of Urology, The First Affiliated Hospital, Zhengzhou University, Institute of Urology of Henan Province, No 1, Jianshe East Road, Zhengzhou, 450052, Henan, China. li_rechee@163.com. 2. Department of Urology, The First Affiliated Hospital, Zhengzhou University, Institute of Urology of Henan Province, No 1, Jianshe East Road, Zhengzhou, 450052, Henan, China. 3. Department of Neonatel Intensive Care Unit, Zhengzhou First People's Hospital, Zhengzhou, 450004, China. 4. College of Pharmacy, Zhengzhou University, Zhengzhou, 450001, China.
Abstract
OBJECTIVE: Recent studies have identified Engrailed-2 (EN-2), a homeobox-containing transcription factor, as a candidate oncogene in prostate cancer (PC). Therapeutic targeting on EN-2, however, is limited because the mechanism underlying EN-2 overexpression in prostatic cancer cells is unknown. This study was to investigate the potential regulatory role of miR-33a on EN-2 expression and explore this signaling axis in ability of prostate cancer survival and metastasis. METHODS: The relative expression of miR-33a and EN-2 in paired prostate cancer tissue and adjacent normal tissue as well as in prostate cancer cell lines, PC3 and DU145, was determined using quantitative real-time PCR or western blot, respectively. Cells survival, migration and invasion were evaluated by assays of MTT, TUNEL and Boyden chamber assays, respectively. Direct regulation of EN-2 by miR-33a was examined by luciferase reporter assay. RESULTS: The data showed that miR-33a was upregulated and EN-2 was downregulated in both prostate cancer tissue and prostate cancer cells. miR-33a overexpression suppresses prostate cancer cell survival and metastasis. miR-33a can directly act on EN-2 expression by binding to 3'UTR of its mRNA. Also, miR-33a negatively regulated EN-2 mRNA and protein expression. In pcDNA-EN-2 and miR-33a mimic co-transfected PC3 and DU145 cells, EN-2 overexpression reverses the anti-cell survival and metastasis actions of miR-33a overexpression. The pivotal role of miR-33a in inhibiting prostate tumor growth was confirmed in xenograft models of prostate cancer. CONCLUSION: Our data suggest that the functional interaction of miR-33a and EN-2 is involved in tumorigenesis of prostate cancer. Also in this process EN-2 serves as a negative responder for miR-33a.
OBJECTIVE: Recent studies have identified Engrailed-2 (EN-2), a homeobox-containing transcription factor, as a candidate oncogene in prostate cancer (PC). Therapeutic targeting on EN-2, however, is limited because the mechanism underlying EN-2 overexpression in prostatic cancer cells is unknown. This study was to investigate the potential regulatory role of miR-33a on EN-2 expression and explore this signaling axis in ability of prostate cancer survival and metastasis. METHODS: The relative expression of miR-33a and EN-2 in paired prostate cancer tissue and adjacent normal tissue as well as in prostate cancer cell lines, PC3 and DU145, was determined using quantitative real-time PCR or western blot, respectively. Cells survival, migration and invasion were evaluated by assays of MTT, TUNEL and Boyden chamber assays, respectively. Direct regulation of EN-2 by miR-33a was examined by luciferase reporter assay. RESULTS: The data showed that miR-33a was upregulated and EN-2 was downregulated in both prostate cancer tissue and prostate cancer cells. miR-33a overexpression suppresses prostate cancer cell survival and metastasis. miR-33a can directly act on EN-2 expression by binding to 3'UTR of its mRNA. Also, miR-33a negatively regulated EN-2 mRNA and protein expression. In pcDNA-EN-2 and miR-33a mimic co-transfected PC3 and DU145 cells, EN-2 overexpression reverses the anti-cell survival and metastasis actions of miR-33a overexpression. The pivotal role of miR-33a in inhibiting prostate tumor growth was confirmed in xenograft models of prostate cancer. CONCLUSION: Our data suggest that the functional interaction of miR-33a and EN-2 is involved in tumorigenesis of prostate cancer. Also in this process EN-2 serves as a negative responder for miR-33a.
Entities:
Keywords:
Engrailed-2; MiR-33a; Migration; Prostate cancer
Authors: Ahmed Fawzy Ibrahim; Ulrike Weirauch; Maren Thomas; Arnold Grünweller; Roland K Hartmann; Achim Aigner Journal: Cancer Res Date: 2011-06-20 Impact factor: 12.701
Authors: Michał Piotr Marszałł; Wiktor Sroka; Marek Adamowski; Piotr Słupski; Piotr Jarzemski; Joanna Siódmiak; Grażyna Odrowąż-Sypniewska Journal: Eur J Cancer Prev Date: 2015-01 Impact factor: 2.497
Authors: Ángela Santonja; Aurelio A Moya-García; Nuria Ribelles; Begoña Jiménez-Rodríguez; Bella Pajares; Cristina E Fernández-De Sousa; Elísabeth Pérez-Ruiz; María Del Monte-Millán; Manuel Ruiz-Borrego; Juan de la Haba; Pedro Sánchez-Rovira; Atocha Romero; Anna González-Neira; Ana Lluch; Emilio Alba Journal: Oncotarget Date: 2022-06-30
Authors: H Q Mu; Y H He; S B Wang; S Yang; Y J Wang; C J Nan; Y F Bao; Q P Xie; Y H Chen Journal: Clin Transl Oncol Date: 2019-10-30 Impact factor: 3.405